Business Segments · Selling, general and administrative expenses
Life Sciences Solutions — Selling, general and administrative expenses
Thermo Fisher Scientific Life Sciences Solutions — Selling, general and administrative expenses decreased by 77.3% to $496M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 76.1%, from $2.08B to $496M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026
Rolls up toSG&A
How to read this metric
Lower ratios relative to revenue suggest better operational leverage and administrative efficiency.
Detailed definition
The operating costs incurred by the Life Sciences Solutions segment that are not directly tied to production, including...
Peer comparison
Standard operating expense category for all corporate segments.
Metric ID:
tmo_segment_life_sciences_solutions_selling_general_and_administrative_expensesHistorical Data
28 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q1 '23 | Q2 '23 | Q2 '23 | Q3 '23 | Q3 '23 | Q4 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.9B | $2B | $2.28B | $2.28B | $2.21B | $2.21B | $2.3B | $2.12B | $441.5M | $2.15B | $441.5M | $2.05B | $441.5M | $2.13B | $441.5M | $2.18B | $2.11B | $2.1B | $475M | $2.2B | $463M | $2.08B | $468M | $468M | $470M | $506M | $2.18B | $496M |
| QoQ Change | — | +5.5% | +13.7% | -0.0% | -3.0% | -0.0% | +4.1% | -7.8% | -79.2% | +385.8% | -79.4% | +364.1% | -78.5% | +382.9% | -79.3% | +394.5% | -3.3% | -0.6% | -77.4% | +363.8% | -79.0% | +348.8% | -77.5% | +0.0% | +0.4% | +7.7% | +331.0% | -77.3% |
| YoY Change | — | — | — | — | +16.3% | +10.2% | +0.9% | -6.9% | -80.6% | -2.9% | -80.0% | -7.2% | -80.0% | -7.3% | -80.8% | +3.0% | -1.6% | +2.4% | -76.8% | +3.3% | -78.3% | -4.8% | -78.6% | -77.8% | -77.6% | -77.0% | +5.0% | -76.1% |
Range$441.5M – $2.3B
CAGR-18.0%
Avg YoY Growth-35.6%
Median YoY Growth-7.2%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's life sciences solutions — selling, general and administrative expenses?
- Thermo Fisher Scientific (TMO) reported life sciences solutions — selling, general and administrative expenses of $496M in Q1 2026.
- How has Thermo Fisher Scientific's life sciences solutions — selling, general and administrative expenses changed year-over-year?
- Thermo Fisher Scientific's life sciences solutions — selling, general and administrative expenses decreased by 76.1% year-over-year, from $2.08B to $496M.
- What does life sciences solutions — selling, general and administrative expenses mean?
- The overhead and selling costs required to run the business operations of the segment.